These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25326175)

  • 41. The M4 insulator, the TM2 matrix attachment region, and the double copy of the heavy chain gene contribute to the enhanced accumulation of the PHB-01 antibody in tobacco plants.
    Ruiz Y; Ramos PL; Soto J; Rodríguez M; Carlos N; Reyes A; Callard D; Sánchez Y; Pujol M; Fuentes A
    Transgenic Res; 2020 Apr; 29(2):171-186. PubMed ID: 31919795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lactococcus lactis as a cell factory for delivery of therapeutic proteins.
    Bahey-El-Din M; Gahan CG; Griffin BT
    Curr Gene Ther; 2010 Feb; 10(1):34-45. PubMed ID: 20156189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient expression systems for plant-derived biopharmaceuticals.
    Komarova TV; Baschieri S; Donini M; Marusic C; Benvenuto E; Dorokhov YL
    Expert Rev Vaccines; 2010 Aug; 9(8):859-76. PubMed ID: 20673010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies.
    Peters J; Stoger E
    Hum Vaccin; 2011 Mar; 7(3):367-74. PubMed ID: 21346415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transient Expression Systems in Plants: Potentialities and Constraints.
    Canto T
    Adv Exp Med Biol; 2016; 896():287-301. PubMed ID: 27165332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recovery and purification of plant-made recombinant proteins.
    Wilken LR; Nikolov ZL
    Biotechnol Adv; 2012; 30(2):419-33. PubMed ID: 21843625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carrot cells: a pioneering platform for biopharmaceuticals production.
    Rosales-Mendoza S; Tello-Olea MA
    Mol Biotechnol; 2015 Mar; 57(3):219-32. PubMed ID: 25572939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives.
    Sala F; Manuela Rigano M; Barbante A; Basso B; Walmsley AM; Castiglione S
    Vaccine; 2003 Jan; 21(7-8):803-8. PubMed ID: 12531364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biopharmaceuticals from plants: a multitude of options for posttranslational modifications.
    Warzecha H
    Biotechnol Genet Eng Rev; 2008; 25():315-30. PubMed ID: 21412360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies.
    Rosales-Mendoza S
    Mol Biotechnol; 2015 Oct; 57(10):869-79. PubMed ID: 26163274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.
    da Cunha NB; Vianna GR; da Almeida Lima T; Rech E
    Biotechnol J; 2014 Jan; 9(1):39-50. PubMed ID: 24376137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using transgenic plants and modified plant viruses for the development of treatments for human diseases.
    Loh HS; Green BJ; Yusibov V
    Curr Opin Virol; 2017 Oct; 26():81-89. PubMed ID: 28800551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plant biopharming of monoclonal antibodies.
    Ko K; Koprowski H
    Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maximizing the Production of Recombinant Proteins in Plants: From Transcription to Protein Stability.
    Feng Z; Li X; Fan B; Zhu C; Chen Z
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plants as bioreactors: Recent developments and emerging opportunities.
    Sharma AK; Sharma MK
    Biotechnol Adv; 2009; 27(6):811-832. PubMed ID: 19576278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioprocessing using novel cell culture systems.
    Parekh S; Srinivasan V; Horn M
    Adv Appl Microbiol; 2008; 63():105-43. PubMed ID: 18395126
    [No Abstract]   [Full Text] [Related]  

  • 58. Magnifection--a new platform for expressing recombinant vaccines in plants.
    Gleba Y; Klimyuk V; Marillonnet S
    Vaccine; 2005 Mar; 23(17-18):2042-8. PubMed ID: 15755568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production and metabolic engineering of bioactive substances in plant hairy root culture.
    Zhou ML; Zhu XM; Shao JR; Tang YX; Wu YM
    Appl Microbiol Biotechnol; 2011 May; 90(4):1229-39. PubMed ID: 21468707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of GFP to investigate expression of plant-derived vaccines.
    Li HY; Chye ML
    Methods Mol Biol; 2009; 515():275-85. PubMed ID: 19378126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.